{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:25Z","timestamp":1786980505027,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T00:00:00Z","timestamp":1512000000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"FP7 Ideas: European Research Council (BE)","award":["2012-305279"],"award-info":[{"award-number":["2012-305279"]}]},{"DOI":"10.13039\/501100003092","name":"Diabetes Fonds","doi-asserted-by":"publisher","award":["2013.81.1674"],"award-info":[{"award-number":["2013.81.1674"]}],"id":[{"id":"10.13039\/501100003092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["310372"],"award-info":[{"award-number":["310372"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NL)","award":["Spinoza"],"award-info":[{"award-number":["Spinoza"]}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["91616083"],"award-info":[{"award-number":["91616083"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s10096-017-3145-y","type":"journal-article","created":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T00:16:45Z","timestamp":1512001005000},"page":"371-380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Patients with type 1 diabetes mellitus have impaired IL-1\u03b2 production in response to Mycobacterium tuberculosis"],"prefix":"10.1007","volume":"37","author":[{"given":"E.","family":"Lachmandas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Thiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hijmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. E.","family":"de Galan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. J.","family":"Tack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"van Crevel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"van Diepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,30]]},"reference":[{"issue":"9","key":"3145_CR1","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S2213-8587(14)70110-X","volume":"2","author":"AL Riza","year":"2014","unstructured":"Riza AL, Pearson F, Ugarte-Gil C, Alisjahbana B, van de Vijver S, Panduru NM, Hill PC, Ruslami R, Moore D, Aarnoutse R, Critchley JA, van Crevel R (2014) Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol 2(9):740\u2013753. \nhttps:\/\/doi.org\/10.1016\/S2213-8587(14)70110-X","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"3145_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/004947559002000402","volume":"20","author":"AB Swai","year":"1990","unstructured":"Swai AB, McLarty DG, Mugusi F (1990) Tuberculosis in diabetic patients in Tanzania. Trop Doct 20(4):147\u2013150. \nhttps:\/\/doi.org\/10.1177\/004947559002000402","journal-title":"Trop Doct"},{"issue":"1","key":"3145_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000666","volume":"2","author":"CC Dobler","year":"2012","unstructured":"Dobler CC, Flack JR, Marks GB (2012) Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study. BMJ Open 2(1):e000666. \nhttps:\/\/doi.org\/10.1136\/bmjopen-2011-000666","journal-title":"BMJ Open"},{"issue":"16","key":"3145_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000096","volume":"93","author":"TC Shen","year":"2014","unstructured":"Shen TC, Lin CL, Wei CC, Liao WC, Chen WC, Chen CH, Tu CY, Hsia TC, Shih CM, Hsu WH, Li CH, Sung FC (2014) Increased risk of tuberculosis in patients with type 1 diabetes mellitus: results from a population-based cohort study in Taiwan. Medicine (Baltimore) 93(16):e96. \nhttps:\/\/doi.org\/10.1097\/MD.0000000000000096","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"3145_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002072","volume":"13","author":"PH Lee","year":"2016","unstructured":"Lee PH, Fu H, Lai TC, Chiang CY, Chan CC, Lin HH (2016) Glycemic control and the risk of tuberculosis: a cohort study. PLoS Med 13(8):e1002072. \nhttps:\/\/doi.org\/10.1371\/journal.pmed.1002072","journal-title":"PLoS Med"},{"issue":"12","key":"3145_CR6","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/aje\/kwn075","volume":"167","author":"CC Leung","year":"2008","unstructured":"Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung GM, Law WS, Tam CM, Chan CK, Chang KC (2008) Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 167(12):1486\u20131494. \nhttps:\/\/doi.org\/10.1093\/aje\/kwn075","journal-title":"Am J Epidemiol"},{"issue":"1","key":"3145_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imr.12257","volume":"264","author":"K Ronacher","year":"2015","unstructured":"Ronacher K, Joosten SA, van Crevel R, Dockrell HM, Walzl G, Ottenhoff TH (2015) Acquired immunodeficiencies and tuberculosis: focus on HIV\/AIDS and diabetes mellitus. Immunol Rev 264(1):121\u2013137. \nhttps:\/\/doi.org\/10.1111\/imr.12257","journal-title":"Immunol Rev"},{"issue":"2","key":"3145_CR8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/CMR.15.2.294-309.2002","volume":"15","author":"R Crevel van","year":"2002","unstructured":"van Crevel R, Ottenhoff TH, van der Meer JW (2002) Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 15(2):294\u2013309","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"3145_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/dmrr.269","volume":"18","author":"EJ Abbink","year":"2002","unstructured":"Abbink EJ, Walker AJ, van der Sluijs HA, Tack CJ, Smits P (2002) No role of calcium- and ATP-dependent potassium channels in insulin-induced vasodilation in humans in vivo. Diabetes Metab Res Rev 18(2):143\u2013148. \nhttps:\/\/doi.org\/10.1002\/dmrr.269","journal-title":"Diabetes Metab Res Rev"},{"issue":"11","key":"3145_CR10","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1002\/eji.201546259","volume":"46","author":"E Lachmandas","year":"2016","unstructured":"Lachmandas E, Beigier-Bompadre M, Cheng SC, Kumar V, van Laarhoven A, Wang X, Ammerdorffer A, Boutens L, de Jong D, Kanneganti TD, Gresnigt MS, Ottenhoff TH, Joosten LA, Stienstra R, Wijmenga C, Kaufmann SH, van Crevel R, Netea MG (2016) Rewiring cellular metabolism via the AKT\/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells. Eur J Immunol 46(11):2574\u20132586. \nhttps:\/\/doi.org\/10.1002\/eji.201546259","journal-title":"Eur J Immunol"},{"key":"3145_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12916-015-0381-9","volume":"13","author":"L Pealing","year":"2015","unstructured":"Pealing L, Wing K, Mathur R, Prieto-Merino D, Smeeth L, Moore DA (2015) Risk of tuberculosis in patients with diabetes: population based cohort study using the UK Clinical Practice Research Datalink. BMC Med 13:135. \nhttps:\/\/doi.org\/10.1186\/s12916-015-0381-9","journal-title":"BMC Med"},{"issue":"3","key":"3145_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121698","volume":"10","author":"CY Chiang","year":"2015","unstructured":"Chiang CY, Bai KJ, Lin HH, Chien ST, Lee JJ, Enarson DA, Lee TI, Yu MC (2015) The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis. PLoS One 10(3):e0121698. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0121698","journal-title":"PLoS One"},{"issue":"12","key":"3145_CR13","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.2337\/dc11-0902","volume":"34","author":"A Leegaard","year":"2011","unstructured":"Leegaard A, Riis A, Kornum JB, Prahl JB, Thomsen V\u00d8, S\u00f8rensen HT, Horsburgh CR, Thomsen RW (2011) Diabetes, glycemic control, and risk of tuberculosis: a population-based case\u2013control study. Diabetes Care 34(12):2530\u20132535. \nhttps:\/\/doi.org\/10.2337\/dc11-0902","journal-title":"Diabetes Care"},{"issue":"4","key":"3145_CR14","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1210\/jcem.77.4.8408455","volume":"77","author":"Y Ohno","year":"1993","unstructured":"Ohno Y, Aoki N, Nishimura A (1993) In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77(4):1072\u20131077. \nhttps:\/\/doi.org\/10.1210\/jcem.77.4.8408455","journal-title":"J Clin Endocrinol Metab"},{"key":"3145_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1196\/annals.1447.053","volume":"1150","author":"MC Foss-Freitas","year":"2008","unstructured":"Foss-Freitas MC, Foss NT, Rassi DM, Donadi EA, Foss MC (2008) Evaluation of cytokine production from peripheral blood mononuclear cells of type 1 diabetic patients. Ann N Y Acad Sci 1150:290\u2013296. \nhttps:\/\/doi.org\/10.1196\/annals.1447.053","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"3145_CR16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2337\/diacare.14.1.63","volume":"14","author":"AD Mooradian","year":"1991","unstructured":"Mooradian AD, Reed RL, Meredith KE, Scuderi P (1991) Serum levels of tumor necrosis factor and IL-1alpha and IL-1beta in diabetic patients. Diabetes Care 14(1):63\u201365","journal-title":"Diabetes Care"},{"issue":"2","key":"3145_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10096-007-0395-0","volume":"27","author":"JE Stalenhoef","year":"2008","unstructured":"Stalenhoef JE, Alisjahbana B, Nelwan EJ, van der Ven-Jongekrijg J, Ottenhoff TH, van der Meer JW, Nelwan RH, Netea MG, van Crevel R (2008) The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 27(2):97\u2013103. \nhttps:\/\/doi.org\/10.1007\/s10096-007-0395-0","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"3145_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112108","volume":"9","author":"NP Kumar","year":"2014","unstructured":"Kumar NP, Banurekha VV, Nair D, Sridhar R, Kornfeld H, Nutman TB, Babu S (2014) Coincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosis. PLoS One 9(11):e112108. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0112108","journal-title":"PLoS One"},{"issue":"3","key":"3145_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1086\/431587","volume":"41","author":"LM Muller","year":"2005","unstructured":"Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, Rutten GE (2005) Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 41(3):281\u2013288. \nhttps:\/\/doi.org\/10.1086\/431587","journal-title":"Clin Infect Dis"},{"issue":"3-4","key":"3145_CR20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","volume":"26","author":"SE Geerlings","year":"1999","unstructured":"Geerlings SE, Hoepelman AI (1999) Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26(3-4):259\u2013265","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"5","key":"3145_CR21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/infdis\/jit241","volume":"208","author":"NP Kumar","year":"2013","unstructured":"Kumar NP, Sridhar R, Banurekha VV, Jawahar MS, Nutman TB, Babu S (2013) Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus. J Infect Dis 208(5):739\u2013748. \nhttps:\/\/doi.org\/10.1093\/infdis\/jit241","journal-title":"J Infect Dis"},{"issue":"5","key":"3145_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1513\/AnnalsATS.201305-112OC","volume":"10","author":"NP Kumar","year":"2013","unstructured":"Kumar NP, Sridhar R, Banurekha VV, Jawahar MS, Fay MP, Nutman TB, Babu S (2013) Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines. Ann Am Thorac Soc 10(5):441\u2013449. \nhttps:\/\/doi.org\/10.1513\/AnnalsATS.201305-112OC","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"3145_CR23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1165\/rcmb.2006-0478OC","volume":"37","author":"GW Martens","year":"2007","unstructured":"Martens GW, Arikan MC, Lee J, Ren F, Greiner D, Kornfeld H (2007) Tuberculosis susceptibility of diabetic mice. Am J Respir Cell Mol Biol 37(5):518\u2013524. \nhttps:\/\/doi.org\/10.1165\/rcmb.2006-0478OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"3145_CR24","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nri3547","volume":"13","author":"AC Shaw","year":"2013","unstructured":"Shaw AC, Goldstein DR, Montgomery RR (2013) Age-dependent dysregulation of innate immunity. Nat Rev Immunol 13(12):875\u2013887. \nhttps:\/\/doi.org\/10.1038\/nri3547","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"3145_CR25","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.2337\/dc07-1960","volume":"31","author":"AS Astrup","year":"2008","unstructured":"Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P (2008) Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate. Diabetes Care 31(6):1170\u20131176. \nhttps:\/\/doi.org\/10.2337\/dc07-1960","journal-title":"Diabetes Care"},{"issue":"5","key":"3145_CR26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/labinvest.3780079","volume":"80","author":"H Yamada","year":"2000","unstructured":"Yamada H, Mizumo S, Horai R, Iwakura Y, Sugawara I (2000) Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha\/beta double-knockout mice. Lab Investig 80(5):759\u2013767","journal-title":"Lab Investig"},{"issue":"3","key":"3145_CR27","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1086\/315771","volume":"182","author":"NP Juffermans","year":"2000","unstructured":"Juffermans NP, Florquin S, Camoglio L, Verbon A, Kolk AH, Speelman P, van Deventer SJ, van Der Poll T (2000) Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J Infect Dis 182(3):902\u2013908. \nhttps:\/\/doi.org\/10.1086\/315771","journal-title":"J Infect Dis"},{"issue":"2","key":"3145_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00281-015-0538-9","volume":"38","author":"I Kramnik","year":"2016","unstructured":"Kramnik I, Beamer G (2016) Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies. Semin Immunopathol 38(2):221\u2013237. \nhttps:\/\/doi.org\/10.1007\/s00281-015-0538-9","journal-title":"Semin Immunopathol"},{"issue":"12","key":"3145_CR29","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.189.12.1863","volume":"189","author":"RJ Wilkinson","year":"1999","unstructured":"Wilkinson RJ, Patel P, Llewelyn M, Hirsch CS, Pasvol G, Snounou G, Davidson RN, Toossi Z (1999) Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med 189(12):1863\u20131874","journal-title":"J Exp Med"},{"issue":"5","key":"3145_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/infdis\/jit572","volume":"209","author":"D Eklund","year":"2014","unstructured":"Eklund D, Welin A, Andersson H, Verma D, S\u00f6derkvist P, Stendahl O, S\u00e4rndahl E, Lerm M (2014) Human gene variants linked to enhanced NLRP3 activity limit intramacrophage growth of Mycobacterium tuberculosis. J Infect Dis 209(5):749\u2013753. \nhttps:\/\/doi.org\/10.1093\/infdis\/jit572","journal-title":"J Infect Dis"},{"issue":"7507","key":"3145_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature13489","volume":"511","author":"KD Mayer-Barber","year":"2014","unstructured":"Mayer-Barber KD, Andrade BB, Oland SD, Amaral EP, Barber DL, Gonzales J, Derrick SC, Shi R, Kumar NP, Wei W, Yuan X, Zhang G, Cai Y, Babu S, Catalfamo M, Salazar AM, Via LE, Barry CE 3rd, Sher A (2014) Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511(7507):99\u2013103. \nhttps:\/\/doi.org\/10.1038\/nature13489","journal-title":"Nature"},{"issue":"4","key":"3145_CR32","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cell.2016.10.018","volume":"167","author":"R Horst ter","year":"2016","unstructured":"ter Horst R, Jaeger M, Smeekens SP, Oosting M, Swertz MA, Li Y, Kumar V, Diavatopoulos DA, Jansen AF, Lemmers H, Toenhake-Dijkstra H, van Herwaarden AE, Janssen M, van der Molen RG, Joosten I, Sweep FC, Smit JW, Netea-Maier RT, Koenders MM, Xavier RJ, van der Meer JW, Dinarello CA, Pavelka N, Wijmenga C, Notebaart RA, Joosten LA, Netea MG (2016) Host and environmental factors influencing individual human cytokine responses. Cell 167(4):1111\u20131124.e13. \nhttps:\/\/doi.org\/10.1016\/j.cell.2016.10.018","journal-title":"Cell"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-017-3145-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-3145-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-3145-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T19:56:18Z","timestamp":1516737378000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-017-3145-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,30]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["3145"],"URL":"https:\/\/doi.org\/10.1007\/s10096-017-3145-y","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,30]]}}}